FDA PMA FDA Class 3 Approved 🇺🇸 United States

Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)

PMA: P090024 · Decision Oct 11, 2011
Classifications
1
FEI Numbers
27
Registration Numbers
27

Basic Information

Device Name
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
Trade Name
ADVIA CENTAUR HBEAG ASSAY AND QUALITY CONTROL MATERIAL
PMA Number
P090024
Device Class
FDA Class 3
Product Code
LOM
Generic Name
Test, hepatitis b (b core, be antigen, be antibody, b core igm)
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
Approved
Decision Code
APPR
Decision Date
October 11, 2011
Date Received
October 22, 2009
Expedited Review
N
Docket Number
11M-0737

Advisory Committee Statement

APPROVAL FOR ADVIA CENTAUR HBEAG ASSAY & ADVIA CENTAUR HBEAG QUALITY CONTROL MATERIAL. THIS DEVICE IS INDICATED FOR:ADVIA CENTAUR HBEAG ASSAY:THE ADVIA CENTAUR HBEAG ASSAY IS AN IN-VITRO DIAGNOSTIC IMMUNOASSAY FOR THE QUALITATIVE DETERMINATION OF THE HEPATITIS B E ANTIGEN (HBEAG) IN HUMAN SERUM AND PLASMA (POTASSIUM EDTA, LITHIUM OR SODIUM HEPARIN) FROM INDIVIDUALS WHO HAVE SIGNS ANDSYMPTOMS OF HEPATITIS OR WHO MAY BE AT RISK FOR HEPATITIS B VIRUS (HBV) INFECTION USING THE ADVIA CENTAUR AND ADVIA CENTAUR XP SYSTEMS. THIS ASSAY, IN CONJUNCTION WITH OTHER SEROLOGICAL AND CLINICAL INFORMATION, IS INTENDED ONLY FOR THE DETERMINATION OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.ADVIA CENTAUR HBEAG QUALITY CONTROL MATERIAL:THE CONTROLS ARE USED FOR MONITORING THE PERFORMANCE OF THE HBEAG ASSAY ON THE ADVIA CENTAUR SYSTEMS. THE PERFORMANCE OF THE HBEAG QUALITY CONTROL MATERIAL HAS NOT BEEN ESTABLISHED WITH ANY OTHER HBEAG ASSAY.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOM Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)